Boditech Launches New Automated Immunoassay Analyzer with Blood Collection Tube at MEDICA 2021
By LabMedica International staff writers Posted on 15 Nov 2021 |
Boditech Med (Gang-won-do, Korea) has launched its new automated immunoassay analyzer with blood collection tube, including an all-in-one cartridge system, at MEDICA 2021.
Boditech’s new POC immunoassay analyzer, AFIAS-10, is a unique integrated Sample-to-Answer system that can execute 10 parallel tests for each different parameter. AFIAS-10 provides a quick and simplified operation and reliable test result with automatically collecting a sample from a blood tube. Boditech showcased its range of parameters that can be executed on the AFIAS-10 covering the areas of cardiac, cancer, diabetes, hormones, infections and autoimmune, among others.
At MEDICA 2021, Boditech also showcased its total solutions for the diagnosis of COVID-19, including ExAmplar COVID-19 real-time PCR kit which comes in ready-to-use mixture and the user can use the reagent without mixing ingredients; the ExAmplex Influenza A/B SARS-CoV-2 PCR kit for the simultaneous PCR detection of COVID-19 and Influenza A/B; and the ExAmplex COVID-19 PCR 3-gene kit which detects two COVID-19 confirmation genes, and one Pan-corona gene with high accuracy.
Among other products, Boditech highlighted its ExAmplar compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges. ExAmplar employs relatively fast thermal cycles (~40 sec) and can deliver the DNA and RNA test results in 30 and 45~55 minutes, respectively. The system runs with dedicated 8-well plates. The reagents for the test come in a dry format, which one can store at room temperature. In addition, Boditech demonstrated the NuActor bench-top & automated nucleic acid (RNA/DNA) extraction system. NuActor is an automated nucleic acid extraction system, used with a ready-to-use cartridge that can be stored at room temperature as a table-top extractor. It can extract concentrated high-purity nucleic acids from a small volume of samples such as blood, cultured cells, and animal tissues quickly and easily.
Related Links:
Boditech Med
Latest Molecular Diagnostics News
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection
- Single Genetic Test to Accelerate Diagnoses for Rare Developmental Disorders